Want to see ADXN full AI Analyst Report?
Addex Therapeutics (ADXN) Financial Statements
Addex Therapeutics Financial Overview
Addex Therapeutics's market cap is currently $3.50M. The company's EPS TTM is $-5.61; its P/E ratio is -0.48; Addex Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 29.97K | $ 404.10K | $ 1.61M | $ 1.42M | $ 2.92M |
| Gross Profit | $ 29.97K | $ 404.10K | $ 1.61M | $ 1.42M | $ 2.92M |
| Operating Income | $ -2.81M | $ -2.76M | $ -2.24M | $ -10.54M | $ -15.51M |
| EBITDA | $ -6.83M | $ -4.65M | $ -2.19M | $ -10.45M | $ -14.94M |
| Net Income | $ -6.73M | $ 7.06M | $ -10.56M | $ -20.80M | $ -15.35M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 1.64M | $ 3.35M | $ 3.87M | $ 6.96M | $ 20.50M |
| Total Assets | $ 6.37M | $ 10.68M | $ 4.64M | $ 8.28M | $ 22.54M |
| Total Debt | $ 34.73K | $ 41.99K | $ 344.34K | $ 373.13K | $ 482.01K |
| Net Debt | $ -1.61M | $ -3.30M | $ -3.52M | $ -6.58M | $ -20.00M |
| Total Liabilities | $ 1.60M | $ 1.00M | $ 3.50M | $ 3.37M | $ 5.61M |
| Stockholders' Equity | $ 4.77M | $ 9.68M | $ 1.15M | $ 4.91M | $ 16.93M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.08M | $ -5.37M | $ -8.00M | $ -16.44M | $ -14.74M |
| Operating Cash Flow | $ -2.08M | $ -5.37M | $ -7.99M | $ -16.44M | $ -14.71M |
| Investing Cash Flow | $ -650.08K | $ 4.65M | $ -6.84K | $ 2.97K | $ -30.31K |
| Financing Cash Flow | $ 1.13M | $ 104.92K | $ 5.26M | $ 3.10M | $ 16.40M |
Currency in CHF